Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Noriyuki Kuniyoshi

Nihon University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 9, 2026 · JOURNAL ARTICLE

Real-World Efficacy and Safety of Gemcitabine, Cisplatin, Plus Immune Checkpoint Inhibitors in Biliary Tract Cancer: A Retrospective Analysis

Cancers

Small retrospective single-centre cohort (n=26) with exploratory design and no powered comparisons; establishes real-world tolerability and PFS data but lacks control group and prospective validation.

PreliminaryCholangiocarcinoma and Gallbladder Cancer Studies Hirofumi Kogure Yoko Oki

Reported

Sample size26

Median age73

Response rate28.6%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support